Live Presentation Available Via Audio-Webcast
BOTHELL, WA, April 29, 2003 - Sonosite, Inc. (Nasdaq: SONO), the leader in point-of-care ultrasound, today announced that Kevin M. Goodwin, president and CEO of Sonosite, will present at the Deutsche Bank Health Care Conference at 9 a.m. (EDT) on Tuesday, May 6, 2003, at the Marriott Baltimore Waterfront Hotel in Baltimore, MD. Interested investors can listen to a live audio-webcast at http://www.visualwebcaster.com/event.asp?id=14061. A replay of the audiocast will be archived on the website for 90 days.
About Sonosite
Sonosite, Inc. (www.sonosite.com) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.… [Read more]
Third Quarter Per Share Loss Reduced to $0.01 from loss of $0.17 in 2002 BOTHELL, WA, October 30, 2003 - Sonosite, Inc. (Nasdaq: SONO), a leading point-of-care ultrasound company, today announced increased revenue and gross margins as well as a reduced loss for the third quarter and nine months ended September 30, 2003.As the Company previously projected in a news release issued on October 13, 2003, Sonosite reported third quarter revenue of $20.2 million, an increase of 10 percent, compared with $18.5 million for the third quarter of 2002. For the nine months of 2003, revenue grew 20 percent to $57.5 million compared with $47.9 million for the same period in the prior year.The Company reported a net loss of $0.2 million, or $0.01 per share, versus a net loss of $2.4 million, or $0.17 per share, for the third quarter of 2002. Earnings per share results were modestly better than projected due to a favorable foreign exchange rate gain. For the nine months, the Company's loss narrowed to $4.0 million, or $0.28 per share, versus a loss of $8.6 million, or $0.68 per share for the same period a year earlier. As of September 30, 2003, cash, cash equivalents and investments totaled $61.6 million.… [Read more]
BOTHELL, WASH., January 21, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that it will present at the Piper Jaffray Health Care Conference at The Pierre in New York on Wednesday, January 26, 2005 at 10:00 am (EST). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://www.sonosite.com/. An archived replay of the presentation will also be available approximately one hour following the live presentation and will be available for 30 days.About Sonosite… [Read more]
TITAN Cardiac Features Bring Full Echo Capabilities to Point Of Care
ACC Sessions Address Growing Importance of IMT
ORLANDO - March 4, 2005 €“ Sonosite, Inc. (Nasdaq: SONO), the world leader in hand carried ultrasound, today announced that the Company will highlight the cardiac capabilities of its high performance TITAN ultrasound system, including the new SonoCalc„¢ IMT (Intima Media Thickness) software for assessment of cardiovascular risk, at the 54th Annual Scientific Session of the American College of Cardiology (ACC) being held from March 6 - 9, 2005.
"For the first time, IMT capability is now offered on a hand-carried ultrasound system, making it easily affordable and accessible in the physician's office," said Kevin M. Goodwin, Sonosite President and CEO. "IMT has long been recognized by the cardiac research community as an effective indicator of heart disease, particularly in people who are otherwise asymptomatic. The numerous scientific sessions on IMT at this ACC indicate a growing interest in moving this technique from research to everyday clinical diagnostic use."
Sonosite is offering a demonstration of its SonoCalc IMT software in booth #3563 at the ACC Scientific Sessions.
Sonosite is also showcasing the recent expansion of capabilities on its high performance TITAN system for the shared service and dedicated echocardiography markets.… [Read more]
BOTHELL, WA - May 24, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that it will present at the Pacific Growth Equities Life Sciences Growth Conference at the InterContinental Mark Hopkins Hotel in San Francisco, Tuesday, June 7th, 2005 at 09:00 am (PDT). The presentation will include a review of the company's business strategy and historical financial results.A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast will find a link to the webcast registration page on Sonosite's website at http://ir.sonosite.com. An archived replay of the presentation will also be available approximately an hour following the live presentation and will be available for 30 days.About Sonosite… [Read more]
Company Reports EPS of $0.05Conference Call Today at 1:30 pm PT/4:30 ETBOTHELL, WA - April 28, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today reported strong financial results for the first quarter ended March 31, 2005.Worldwide revenue in the first quarter of 2005 grew 44% to $34.0 million compared with $23.5 million in the first quarter of 2004. The company achieved pre-tax income of $1.4 million in the first quarter of 2005 and reported net income in the first quarter of $725,000, or $0.05 per diluted share, compared with a loss of $1.4 million, or $0.10 per share, a year ago."The year is off to an exceptionally strong start," said Kevin M. Goodwin, Sonosite President and CEO. "The quarter's outstanding results were due to excellent execution in both US and International markets. During the second quarter we will be focused on the worldwide launch of the MicroMaxx„¢ system, our third generation of hand-carried ultrasound technology. We will be hosting events in the US, Canada, Europe and Asia to give physicians and sonographers a first hand look at this powerful yet lightweight system and we plan to begin customer shipments in mid-June."… [Read more]
BOTHELL, WA - October 27, 2008 - Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in hand-carried ultrasound for point of care medicine, announced today the introduction of SonoGT™ Global Targeted technology, an advance that capitalizes on the power of the M-Turbo platform to drive a new level of color flow imaging, wireless connectivity and workflow integration for anesthesia, emergency medicine, critical care and other acute point-of-care markets. "SonoGT technology demonstrates the intrinsic capabilities of the M-Turbo system architecture to address our global, multiple point-of-care markets with targeted solutions," said Kevin M. Goodwin, Sonosite President and CEO. "This advance is aimed at increasing imaging capabilities and clinical productivity and includes a wide range of new technologies and options." The company plans to begin customer shipments of new M-Turbo systems with SonoGT technology in the fourth quarter. Customers can separately purchase SonoGT technology and upgrade existing M-Turbo systems via an easy software download from a USB thumb drive. The new SonoGT technology platform offers the following capabilities: Color Performance
ColorHD™ Technology - A proprietary, color Doppler algorithm that harnesses the power of the M-Turbo system's digital signal processor to increase color performance, sensitivity and frame rates.
… [Read more]
BOTHELL, WA - July 30, 2007 - Sonosite, Inc., (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today it has acquired LumenVu, Inc., a privately held, development stage company based in Philadelphia. LumenVu, in conjunction with a leading academic research institution, has developed a patented technology to improve the accuracy of catheter placement. The acquisition will strengthen Sonosite's position in the vascular access market as well as add a recurring revenue stream via the disposable catheter guidance device. Sonosite expects to introduce products based on this technology in late 2008. Terms of the agreement were not disclosed and the transaction is not expected to have a material effect on Sonosite's 2007 financial results."The combination of Sonosite's hand-carried ultrasound technology with LumenVu's innovative catheter tracking technology will offer clinicians a major benefit in accurately and cost-effectively placing catheters at the bedside," said Thomas J. Dugan, Senior Vice President, Global Marketing and US Sales. "Clinicians have been rapidly adopting Sonosite's hand-carried ultrasound systems to increase the accuracy and speed of catheter insertion. LumenVu's technology will offer the perfect complement to ultrasound by providing a way to easily track the tip of the catheter as it advances through the vessel to ensure that it is placed in the right location, potentially eliminating the need to confirm the location with x-ray or fluoroscopy."… [Read more]
BOTHELL, WA - August 20, 2007 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand carried ultrasound, announced today it has appointed Marcus Y. Smith as Vice President, Corporate Development. In that position, Mr. Smith will be a member of Sonosite's Executive Committee and report to Kevin M. Goodwin, Sonosite President and CEO. Mr. Smith joins Sonosite from Philips Medical Systems (PMS) where he served as Senior Director, Strategy and Business Development since 2004. In this capacity he was responsible for directing strategy and business development efforts for Patient Monitoring and Cardiac Care, a $1 billion medical technology division of PMS. While at Philips, Mr. Smith built and executed on a strong portfolio of growth opportunities focused on strengthening core business and expansion into new critical care markets. From 2000 to 2003, Mr. Smith led JPMorgan's European logistics investment banking practice as Vice President, Investment Banking for the firm and advised major corporate and government clients on strategic alternatives in the logistics and transportation sectors. He originated and executed a broad range of transactions, including mergers, acquisitions, joint ventures, strategic alliances, equity, debt and derivatives.… [Read more]
BOTHELL, WA - July 16, 2007 - Sonosite, Inc., (Nasdaq:SONO), the world leader in hand-carried ultrasound, today announced the closing of its offering of $200 million aggregate principal amount of Convertible Senior Notes due 2014 in an offering registered under the Securities Act of 1933 as amended (the "Securities Act"). The notes will pay interest semiannually at a rate of 3.75% per annum. In certain circumstances, the notes will be convertible based on an initial conversion rate of 26.1792 shares of common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $38.20 per share. Conversions will be settled in cash up to the principal amount of the notes, with any conversion value above the principal amount settled in shares of Sonosite's common stock. Holders of the notes may require Sonosite to repurchase the notes for cash equal to 100% of the principal amount to be repurchased plus accrued and unpaid interest upon the occurrence of a fundamental change. Sonosite has granted the underwriters a 30-day option to purchase up to $25 million in aggregate principal amount of additional notes to cover over-allotments.… [Read more]
Judge Reverses Earlier Infringement RulingGrants Sonosite Motion For Summary Judgment
BOTHELL, WA - March 22, 2006 - Sonosite, Inc. (Nasdaq:SONO), the world leader in hand-carried ultrasound, announced today that the United States District Court for the Southern District of Texas, Houston Division, has granted Sonosite's motion for summary judgment of invalidity against Neutrino Development Corporation (Neutrino), a patent holding company. Based on the holding of invalidity, the court reversed its earlier finding that Sonosite infringed Neutrino's patent, US Patent No. 6,221,021 ("the '021 patent").
"This is a major victory for Sonosite and we are very pleased that the judge agreed with us that our products do not infringe Neutrino's patent," said Kevin M. Goodwin, Sonosite President and CEO. "Our technology and products are based on years of innovation and dedication by our employees. We look forward to having the distraction of this unfounded lawsuit behind us and continuing to develop products that are changing medical practice by bringing the benefits of ultrasound visualization to the point of patient care."
In the ruling issued yesterday, March 21, 2006, the court found that Neutrino improperly amended the '021 patent in violation of US patent law to include a claim of a component being handheld which was not in the original patent application.… [Read more]
Leading Health Care Group Purchasing Organization Adds State-of-Art Hand-Carried Ultrasound Systems to its National Contract PortfolioBOTHELL, WA - August 30, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, today announced it has signed a three-year, dual-source supply agreement with Novation for portable and vascular access ultrasound equipment and accessories. Novation is the supply company of VHA Inc. and the University Health System Consortium (UHC), two national health care alliances that serve approximately 2,500 health care providers nationwide. "We awarded this agreement to Sonosite based on member surveys, the recommendation of our member-based Diagnostic Imaging Capital Equipment task force and a public competitive bid process," said Cynthia Longueville, Novation senior product manager. "Novation looks forward to working with Sonosite to provide VHA and UHC members products that offer the best combination of quality, service and value."… [Read more]
BOTHELL, WA - August 10, 2005 - Sonosite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, announced today the appointment of Graham D. Cox as Vice President of its international business. Henry (Skip) A. Krause, who has led Sonosite's international division for the past two years, is resigning his position for personal family reasons, effective September 12, 2005."Skip has made significant contributions to expanding our presence into new international markets and successfully re-engineered our distribution in Japan," said Kevin M. Goodwin, Sonosite President and CEO. "We appreciate his efforts and wish Skip and his family all the best in the future.""We are fortunate to have an executive of Graham Cox's caliber and ultrasound experience who is well qualified to immediately assume leadership of our international business," Goodwin said. "Graham's proven leadership in establishing and growing our operations in Europe, Africa and the Middle East, provides an excellent base from which to lead and maintain our strong momentum in international markets."… [Read more]
Conference Call Accessible Via Live WebcastBOTHELL, WA - April 14, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced that the Company will report its first quarter financial results on Thursday, April 28, 2005 at the close of market and hold a conference call at 1:30 pm PT/4:30 pm ET to discuss its first quarter performance, outlook for 2005 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com.A replay of the audio webcast will be available beginning April 28, 2005, 4:30 pm (PT) until May 11, 2005, 12:00 midnight (PT) by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7405545 is required to access the replay. The call will be also archived on the Sonosite website.About Sonosite… [Read more]
Revolutionary Combination of Cost, Performance and Size Promises to Bring Benefits of Ultrasound to More Doctors and PatientsCustomer Shipments to begin in JuneBOTHELL, WA - April 18, 2005 - Sonosite, Inc. (Nasdaq: SONO), the world leader in hand-carried ultrasound, today announced the worldwide launch of its MicroMaxx„¢ ultrasound system, the company's third generation hand-carried product. The MicroMaxx system, at less than eight pounds and the size of a laptop computer, delivers image resolution and performance comparable to costly, conventional cart-based ultrasound systems weighing over 200 pounds. This unprecedented power in a hand-carried configuration provides caregivers with unmatched flexibility and efficiency in utilizing ultrasound in both hospital and office-based settings.… [Read more]
Sonosite Hand-carried Ultrasound Systems Integral Part of Medical Support at the Winter Games… [Read more]
BOTHELL, WA, July 30, 2002 - Sonosite, Inc. (Nasdaq: SONO) today announced that, effective August 5, Jens U. Quistgaard, Ph.D., Sonosite's chief product and strategy officer, will leave the Company to become the president and chief executive officer of LipoSonix, Inc., a private company based in the Seattle area.
LipoSonix is developing medical devices for cosmetic surgery applications and is not a Sonosite competitor. "Jens has been with Sonosite since the beginning when we were the Handheld Systems Business Group at ATL Ultrasound five years ago," said Kevin M. Goodwin, Sonosite's president and CEO.
"Under his leadership, our product development and marketing groups have delivered ground-breaking products and strong market progress. Jens deserves an opportunity like this, and we wish him the best. "Blake Little, vice president of engineering, will become the Company's senior engineering officer and technology spokesperson," Goodwin continued. "Blake has been instrumental in the development and release of all of Sonosite's products, including our newest product line that we will be launching in the next several weeks.… [Read more]
A Tool to Improve Post-Operative Surgical Outcomes and Reduce Hospital Costs
Non-invasive System to Assist in Fluid Management
Technology Debuts at the 2011 American Society of Anesthesiologists Conference (ASA) October 15-17th, Booth #2242
BOTHELL, WA - October 13, 2011 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in bedside and point-of-care ultrasound, today introduced the new BioZ® Cardio Profile system with impedance cardiography (ICG) technology for non-invasively monitoring a patient's hemodynamic profile in the hospital. Pioneered by NASA in the 1960's, ICG hemodynamic monitoring has traditionally been used to treat patients with heart failure and hypertension, and it is now ready to play a significant role in the anesthesia suite.… [Read more]